ロード中...
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Schizophrenia is a debilitating illness with a lifetime prevalence estimate of 0.6% and consists of symptoms from the positive, negative, and cognitive domains. Social support, therapy, psychoeducation, and overall case management are very important aspects of the treatment of schizophrenia. However...
保存先:
| 出版年: | Drugs |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8318953/ https://ncbi.nlm.nih.gov/pubmed/34196945 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-021-01556-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|